Target Name: MIR3908
NCBI ID: G100500909
Review Report on MIR3908 Target / Biomarker Content of Review Report on MIR3908 Target / Biomarker
MIR3908
Other Name(s): hsa-mir-3908 | hsa-miR-3908 | MicroRNA 3908 | microRNA 3908

MIR3908: A Potential Drug Target and Biomarker

Molecular Targets and Biomarkers

MIR3908 is a small non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the cell cycle and has been shown to play a critical role in the development and progression of various diseases, including cancer.

The discovery of MIR3908 as a potential drug target and biomarker has significant implications for the development of new treatments for these diseases. By targeting MIR3908, researchers can inhibit its activity and potentially disrupt the cell cycle, leading to the inhibition of cell growth and division, and the regression of cancer cells.

MIR3908 is a small molecule that can be easily synthesized and is relatively non-toxic. It has been shown to be effective in animal models of cancer, and it is currently being tested in clinical trials as a potential drug for the treatment of various cancers, including breast, ovarian, and colorectal cancers.

One of the key advantages of MIR3908 is its ability to cross cell membranes and its low toxicity. This allows it to be easily administered to patients and provides a high degree of safety. Additionally, because MIR3908 is a small molecule, it can be easily administered in pill form, which is a convenient and cost-effective form for patients.

MIR3908 has also been shown to be a strong biomarker for cancer. It has been shown to be significantly elevated in the blood and urine of patients with various cancers, and it has been used as a marker for the diagnosis and monitoring of these cancers.

In addition to its potential use as a drug target and biomarker, MIR3908 has also been shown to have a variety of other biological functions. For example, it has been shown to play a role in the regulation of cell adhesion, and it has been shown to interact with a variety of proteins, including the T-cell receptor alpha chain.

MIR3908 is also a good candidate for a repurpose drug, which is a drug that is currently being used to treat one disease but has the potential to be used to treat another related disease. For example, MIR3908 has been shown to be effective in treating skin tags, which are a common type of cancer that affects the skin.

In conclusion, MIR3908 is a promising drug target and biomarker that has the potential to revolutionize the treatment of cancer. Its small size, ease of synthesis, and low toxicity make it an attractive candidate for further study and potential clinical use. Additionally, its potential as a repurpose drug further increases its potential as a therapeutic tool.

Protein Name: MicroRNA 3908

The "MIR3908 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3908 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR3909 | MIR3910-1 | MIR3910-2 | MIR3911 | MIR3912 | MIR3913-1 | MIR3913-2 | MIR3914-1 | MIR3914-2 | MIR3915 | MIR3916 | MIR3917 | MIR3918 | MIR3919 | MIR3920 | MIR3921 | MIR3922 | MIR3923 | MIR3924 | MIR3925 | MIR3926-1 | MIR3926-2 | MIR3927 | MIR3928 | MIR3929 | MIR3934 | MIR3935 | MIR3936 | MIR3936HG | MIR3937 | MIR3938 | MIR3939 | MIR3940 | MIR3941 | MIR3942 | MIR3943 | MIR3944 | MIR3945 | MIR3945HG | MIR3960 | MIR3972 | MIR3973 | MIR3974 | MIR3976 | MIR3976HG | MIR3977 | MIR3978 | MIR409 | MIR410 | MIR411 | MIR412 | MIR421 | MIR422A | MIR423 | MIR424 | MIR425 | MIR4251 | MIR4252 | MIR4253 | MIR4254 | MIR4255 | MIR4256 | MIR4257 | MIR4258 | MIR4259 | MIR4260 | MIR4261 | MIR4262 | MIR4263 | MIR4264 | MIR4265 | MIR4266 | MIR4267 | MIR4268 | MIR4269 | MIR4270 | MIR4271 | MIR4272 | MIR4273 | MIR4274 | MIR4275 | MIR4276 | MIR4277 | MIR4278 | MIR4279 | MIR4280 | MIR4281 | MIR4282 | MIR4283-1 | MIR4283-2 | MIR4284 | MIR4285 | MIR4286 | MIR4287 | MIR4288 | MIR4289 | MIR429 | MIR4290 | MIR4291 | MIR4292